|
000
| 01753nam 2200349zi 4500 |
|---|
| 001 | 9.862683 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240724140218 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 181002s2018 onc o f000 0 eng d |
|---|
| 020 | |a9780660279985 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-243/2018E-PDF |
|---|
| 245 | 00|aPerformance standards for the fees in respect of drugs and medical devices order. |
|---|
| 250 | |a[November 22, 2018 edition]. |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c2018. |
|---|
| 300 | |a1 online resource (9 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Normes de rendement pour l’arrêté sur les prix à payer à l’égard des drogues et instruments médicaux. |
|---|
| 500 | |aCover title. |
|---|
| 500 | |a"Published: November 22, 2018." |
|---|
| 520 | |a"The purpose of this document is to provide the performance standards to be used to determine whether a remission should be granted, under the Fees in Respect of Drugs and Medical Devices Order (Order), to a person who must pay a fee under that Order"--page 1. |
|---|
| 692 | 07|2gccst|aFees |
|---|
| 692 | 07|2gccst|aMedical products |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |
|---|
| 775 | 08|tNormes de rendement pour l’arrêté sur les prix à payer à l’égard des drogues et instruments médicaux.|w(CaOODSP)9.862684 |
|---|
| 794 | |tPerformance standards for the fees in respect of drugs and medical devices order.|b[November 1, 2022 edition]|w(CaOODSP)9.920033 |
|---|
| 856 | 40|qPDF|s458 KB|uhttps://publications.gc.ca/collections/collection_2019/sc-hc/H164-243-2018-eng.pdf |
|---|